兴华创新医疗6个月持有混合发起C(013921)资产负债表
|
2024-06-30 |
2023-12-31 |
2023-06-30 |
2022-12-31 |
资产 |
银行存款 |
- |
- |
1,318,927.08 |
2,323,256.12 |
结算备付金 |
6,207.34 |
6,196.26 |
6,169.11 |
6,142.37 |
存出保证金 |
- |
- |
- |
- |
交易性金融资产 |
10,479,099.25 |
17,401,318.88 |
20,398,310.28 |
25,595,655.71 |
其中:股票投资 |
10,479,099.25 |
17,401,318.88 |
20,398,310.28 |
25,595,655.71 |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
- |
- |
- |
应收利息 |
- |
- |
- |
- |
应收股利 |
20,910.51 |
- |
2,640.00 |
- |
应收申购款 |
352.18 |
1,551.28 |
5,109.84 |
4,599.11 |
其他资产 |
- |
- |
- |
- |
资产总计 |
11,440,162.34 |
19,008,926.91 |
21,731,156.31 |
27,929,653.31 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
192,156.70 |
- |
- |
151,933.42 |
应付赎回款 |
51.05 |
469.82 |
5,089.06 |
28.94 |
应付管理人报酬 |
11,862.63 |
19,860.06 |
27,914.16 |
35,020.76 |
应付托管费 |
1,977.14 |
3,310.00 |
4,652.34 |
5,836.79 |
应付销售服务费 |
880.35 |
1,258.81 |
1,403.02 |
1,974.60 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
12,432.42 |
25,000.00 |
14,876.39 |
150,000.00 |
负债合计 |
219,360.29 |
49,898.69 |
53,934.97 |
344,794.51 |
所有者权益 |
实收基金 |
22,592,766.04 |
28,881,086.16 |
28,951,588.24 |
32,246,616.23 |
未分配利润 |
-11,371,963.99 |
-9,922,057.94 |
-7,274,366.90 |
-4,661,757.43 |
所有者权益合计 |
11,220,802.05 |
18,959,028.22 |
21,677,221.34 |
27,584,858.80 |
负债及所有者权益总计 |
11,440,162.34 |
19,008,926.91 |
21,731,156.31 |
27,929,653.31 |